The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
暂无分享,去创建一个
Jacek Kopec | Josep Maria Haro | Wayne Hall | Mohsen Naghavi | Jürgen Rehm | Louisa Degenhardt | Stein Emil Vollset | Michael Phillips | Joshua Salomon | Emmanuela Gakidou | Kyle Foreman | Juanita Haagsma | Benn Sartorius | James G. Scott | Theo Vos | George Patton | Ali Mokdad | T. Vos | C. Murray | M. Naghavi | A. Ferrari | H. Erskine | H. Whiteford | S. Hay | P. Allebeck | F. Charlson | Kyle Foreman | E. Gakidou | J. Haagsma | J. Haro | A. Knudsen | J. Kopec | J. Leung | G. Patton | M. Phillips | J. Salomon | D. Santomauro | B. Sartorius | Mari Smith | R. Topor-Madry | S. Vollset | J. Rehm | W. Hall | S. Lim | A. Mokdad | L. Degenhardt | Max G Griswold | Peter Allebeck | Ann Kristin Knudsen | Roman Topor-Madry | Max Griswold | Janni Leung | Harvey Whiteford | John McGrath | Deborah Carvalho Malta | Mari Smith | Christopher Murray | Damian Santomauro | Alize Ferrari | Stephen Lim | James Scott | Simon Hay | Fiona Charlson | Holly Erskine | Louisa Fiona Alize Damian Holly Ana Harvey Janni Mohsen M Degenhardt Charlson Ferrari Santomauro Ers | Ana Mantilla-Herrara | J. Mcgrath | D. Carvalho Malta | Ana Mantilla-Herrara | Deborah Carvalho Malta
[1] R. Kessler,et al. Concordance between the diagnostic guidelines for alcohol and cannabis use disorders in the draft ICD‐11 and other classification systems: analysis of data from the WHO's World Mental Health Surveys , 2018, Addiction.
[2] Dan J Stein,et al. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2018, Lancet.
[3] J. Leung,et al. Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review , 2017, The Lancet. Global health.
[4] R. Kessler,et al. Estimating treatment coverage for people with substance use disorders: an analysis of data from the World Mental Health Surveys , 2017, World psychiatry : official journal of the World Psychiatric Association.
[5] Eyal Oren,et al. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 , 2017, Lancet.
[6] Eyal Oren,et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.
[7] Dan J Stein,et al. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.
[8] Eyal Oren,et al. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.
[9] Mohammad Hossein Khosravi,et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, Lancet.
[10] L. Barajas-Nava. Oral Substitution Treatment of Injecting Opioid Users for Prevention of HIV Infection , 2017, The Journal of the Association of Nurses in AIDS Care : JANAC.
[11] N. Campbell,et al. Twenty years of take-home naloxone for the prevention of overdose deaths from heroin and other opioids-Conception and maturation. , 2017, Drug and alcohol dependence.
[12] T. Vos,et al. Global, regional, and national incidence and prevalence, and years lived with disability for 328 diseases and injuries in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017 .
[13] S. Popova,et al. The relationship between different dimensions of alcohol use and the burden of disease—an update , 2017, Addiction.
[14] L. Degenhardt,et al. A systematic review of injecting-related injury and disease among people who inject drugs. , 2017, Drug and alcohol dependence.
[15] T. Vos,et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement , 2016, PLoS medicine.
[16] T. Vos,et al. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. , 2016, The Lancet. Infectious diseases.
[17] L. Amato,et al. Psychosocial interventions for psychostimulant misuse. , 2016, The Cochrane database of systematic reviews.
[18] J. Rehm,et al. Evidence of reducing ethanol content in beverages to reduce harmful use of alcohol. , 2016, The lancet. Gastroenterology & hepatology.
[19] M. Petticrew,et al. What the InBev merger means for health in Africa , 2016, BMJ Global Health.
[20] S. Pearson,et al. National trends in alcohol pharmacotherapy: Findings from an Australian claims database. , 2016, Drug and alcohol dependence.
[21] R. Bruno,et al. Concordance of ICD-11 and DSM-5 definitions of alcohol and cannabis use disorders: a population survey. , 2016, The lancet. Psychiatry.
[22] Daniel C. Casey,et al. Alcohol‐attributed disease burden in four Nordic countries: a comparison using the Global Burden of Disease, Injuries and Risk Factors 2013 study , 2016, Addiction.
[23] J. Copeland,et al. Psychosocial interventions for cannabis use disorder. , 2016, The Cochrane database of systematic reviews.
[24] S. Popova,et al. Comorbidity of fetal alcohol spectrum disorder: a systematic review and meta-analysis , 2016, The Lancet.
[25] W. Hall,et al. The health and social effects of nonmedical cannabis use. , 2016 .
[26] Mirjam Kretzschmar,et al. Disability weights for the Global Burden of Disease 2013 study. , 2015, The Lancet. Global health.
[27] M. Forsman,et al. Comparison of DSM-5 Classifications of Alcohol Use Disorders With Those of DSM-IV, DSM-III-R, and ICD-10 in a General Population Sample in Sweden. , 2015, Journal of studies on alcohol and drugs.
[28] G. Dore,et al. The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention , 2015, Current opinion in HIV and AIDS.
[29] B. Grant,et al. The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings , 2015, Social Psychiatry and Psychiatric Epidemiology.
[30] B. Grant,et al. Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. , 2015, Journal of studies on alcohol and drugs.
[31] T. Vos,et al. Assessing disability weights based on the responses of 30,660 people from four European countries , 2015, Population Health Metrics.
[32] T. Babor,et al. The concentration of the global alcohol industry and its penetration in the African region. , 2015, Addiction.
[33] Janet B W Williams. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[34] J. Rehm,et al. Global alcohol exposure estimates by country, territory and region for 2005--a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. , 2013, Addiction.
[35] J. Rehm,et al. Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union , 2013, European Neuropsychopharmacology.
[36] Alan D. Lopez,et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 , 2012, The Lancet.
[37] P. Vickerman,et al. Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis , 2012, BMJ : British Medical Journal.
[38] Wayne Hall,et al. Extent of illicit drug use and dependence, and their contribution to the global burden of disease , 2012, The Lancet.
[39] J. Parry,et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. , 2011, Addiction.
[40] L. Degenhardt,et al. What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. , 2011, Drug and alcohol dependence.
[41] L. Degenhardt,et al. Opioid dependence latent structure: two classes with differing severity? , 2011, Addiction.
[42] Lawrence D Phillips,et al. Drug harms in the UK: a multicriteria decision analysis , 2010, The Lancet.
[43] T. Rhodes,et al. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed , 2010, The Lancet.
[44] S. Popova,et al. The relation between different dimensions of alcohol consumption and burden of disease: an overview. , 2010, Addiction.
[45] A. Brennan,et al. Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model , 2010, The Lancet.
[46] B. Grant,et al. Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the US example , 2010, Population health metrics.
[47] D. Segal. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) , 2010 .
[48] Øystein Bakke,et al. Vested Interests in Addiction Research and Policy Alcohol policies out of context: drinks industry supplanting government role in alcohol policies in sub-Saharan Africa , 2010, Addiction.
[49] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.
[50] R P Mattick,et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2009, The Cochrane database of systematic reviews.
[51] D. Chisholm,et al. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol , 2009, The Lancet.
[52] R. Mcketin,et al. Major physical and psychological harms of methamphetamine use. , 2008, Drug and alcohol review.
[53] C. Record. A framework convention on alcohol control , 2007, The Lancet.
[54] T. Lancet. A Framework Convention on Alcohol Control , 2007, The Lancet.
[55] Josep Maria Haro,et al. Delay and failure in treatment seeking after first onset of mental disorders in the World Health Organization's World Mental Health Survey Initiative. , 2007, World psychiatry : official journal of the World Psychiatric Association.
[56] I. Levav,et al. Treatment gap in mental health care. , 2004, The Israel journal of psychiatry and related sciences.
[57] Alan D. Lopez,et al. Comparative quantification of health risks: Conceptual framework and methodological issues , 2003, Population health metrics.
[58] C. Murray,et al. On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. , 1999, Epidemiology.
[59] Dean T. Jamison,et al. World development report 1993 : investing in health , 1993 .
[60] C. Beyrer,et al. What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries. , 2014, The International journal on drug policy.
[61] L. Degenhardt,et al. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. , 2011, Addiction.
[62] R. Mattick,et al. Predictors of social anxiety in an opioid dependent sample and a control sample. , 2010, Journal of anxiety disorders.
[63] R. Mattick,et al. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. , 2008, The Cochrane database of systematic reviews.
[64] BOMBAY CALCUrIA,et al. World development report 1993--investing in health. , 1993, Communicable disease report. CDR weekly.